6-Fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene

Product Overview

6-Fluoro-2-(oxiran-2-yl)-3,4-dihydro-2H-chromene is a specialized organic compound characterized by its fluorinated benzopyran structure and reactive epoxide functionality. This chemical serves as a critical building block in the pharmaceutical industry, specifically designed for the multi-step synthesis of advanced cardiovascular therapeutics. The presence of the fluorine atom at the sixth position enhances metabolic stability and bioavailability in downstream drug molecules, making this intermediate highly valued for modern medicinal chemistry applications.

Our manufacturing process ensures consistent molecular integrity, with a focus on minimizing regio-isomers and structural impurities. The compound is supplied as a yellow liquid, reflecting its high concentration and purity levels suitable for immediate use in sensitive organic synthesis reactions. We adhere to strict production protocols to guarantee batch-to-batch reproducibility, which is essential for large-scale pharmaceutical manufacturing.

Technical Specifications

The following table outlines the key physical and chemical properties of this intermediate. All parameters are verified through rigorous analytical testing including HPLC, NMR, and GC-MS to ensure compliance with international pharmaceutical standards.

Pharmaceutical Applications

This compound is primarily utilized as a key intermediate in the synthesis of Nebivolol hydrochloride, a third-generation beta-blocker used for the treatment of hypertension and heart failure. The epoxide ring within the structure allows for precise nucleophilic attack during the coupling stages of drug synthesis, facilitating the formation of the desired stereochemistry required for therapeutic efficacy.

Chemists value this intermediate for its reactivity profile and stability under standard storage conditions. The fluorine substitution pattern is crucial for optimizing the pharmacokinetic properties of the final active pharmaceutical ingredient. Our product supports research and development teams as well as commercial production facilities aiming to produce high-quality cardiovascular medications.

Quality Assurance and Safety

Quality is paramount in pharmaceutical intermediate supply. Each batch undergoes comprehensive testing to verify identity, purity, and impurity profiles. We provide a Certificate of Analysis (COA) with every shipment, detailing the results of our internal quality control measures. Our facilities operate under guidelines that emphasize safety and environmental responsibility.

Regarding safety handling, this substance should be treated with care due to its chemical reactivity. It is recommended to use appropriate personal protective equipment including gloves and safety goggles. The flash point indicates that while it is not highly volatile at room temperature, precautions against ignition sources are necessary during storage and transfer operations.

Packaging and Storage

To maintain product integrity during transit, we offer flexible packaging solutions tailored to customer requirements. The standard packaging consists of 25kg cardboard drums, which are sealed to prevent moisture ingress and contamination. For larger volume orders, we can arrange bulk packaging in accordance with international shipping regulations for chemical goods.

Storage conditions require a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizing agents. Containers must be kept tightly closed when not in use to prevent degradation. We support global logistics networks to ensure timely delivery to manufacturing sites worldwide, accompanied by all necessary documentation for customs clearance and regulatory compliance.